ADVERTISEMENT
News
InnovaMatrix AC - Convatec
10/01/2024
https://www.convatecgroup.com/media/press-releases/2024/convatec_update_on_innovamatrix_ac_clinical_data/
Convatec is progressing in generating and disseminating clinical evidence for InnovaMatrix AC. Results from the 1st phase of its RWE, including VLUs, DFUs and other indications, will be published in H224 and H125. Its 120-patient clinical study for VLUs is currently recruiting patients.